The Current Ratio as of September 2024 (TTM) for ADC Therapeutics SA (ADCT) is 6.17

According to ADC Therapeutics SA’s latest financial reports and current stock price. The company's current Current Ratio is 6.17. This represents a change of 20.04% compared to the average of 5.14 of the last 4 quarters.

ADC Therapeutics SA (ADCT) Historical Current Ratio (quarterly & annually)

How has ADCT Current Ratio performed in the past?

The mean historical Current Ratio of ADC Therapeutics SA over the last ten years is 8.60. The current 6.17 Current Ratio has changed 7.07% with respect to the historical average. Over the past ten years (40 quarters), ADCT's Current Ratio was at its highest in in the September 2020 quarter at 15.55. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

ADC Therapeutics SA (ADCT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ADC Therapeutics SA Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ADC Therapeutics SA (ADCT) Average Current Ratio

How has ADCT Current Ratio performed in the past?

The current Current Ratio of ADC Therapeutics SA (ADCT) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ADC Therapeutics SA (ADCT) Current Ratio vs. Peers

How is ADCT’s Current Ratio compared to its peers?

ADC Therapeutics SA’s Current Ratio is less than Passage Bio, Inc. (7.67), less than Black Diamond Therapeutics, Inc. (6.87), greater than TCR2 Therapeutics Inc. (2.96), greater than Harpoon Therapeutics, Inc. (1.89), greater than Alector, Inc. (3.52), less than Century Therapeutics, Inc. (10.62), greater than Homology Medicines, Inc. (4.19), less than Generation Bio Co. (7.42), less than Stoke Therapeutics, Inc. (6.67), greater than Ultragenyx Pharmaceutical Inc. (3.54), less than Crinetics Pharmaceuticals, Inc. (16.09), greater than Arvinas, Inc. (3.62), less than Revolution Medicines, Inc. (15.42), less than Kura Oncology, Inc. (14.94), less than Akero Therapeutics, Inc. (24.89), less than Avidity Biosciences, Inc. (15.78), less than Protagonist Therapeutics, Inc. (13.73), less than Design Therapeutics, Inc. (41.42), greater than ALX Oncology Holdings Inc. (4.39), greater than Aadi Bioscience, Inc. (4.20), less than AlloVir, Inc. (55.08),

Build a custom stock screener for ADC Therapeutics SA (ADCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ADC Therapeutics SA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ADC Therapeutics SA (ADCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ADC Therapeutics SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.